GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pediatrix Medical Group Inc (NYSE:MD) » Definitions » Net Income

MD (Pediatrix Medical Group) Net Income : $-99 Mil (TTM As of Dec. 2024)


View and export this data going back to 1959. Start your Free Trial

What is Pediatrix Medical Group Net Income?

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. Pediatrix Medical Group's Net Income for the three months ended in Dec. 2024 was $30 Mil. Its Net Income for the trailing twelve months (TTM) ended in Dec. 2024 was $-99 Mil.

Net Income is linked to the most popular Earnings per Share (Diluted) number. Pediatrix Medical Group's Earnings per Share (Diluted) for the three months ended in Dec. 2024 was $0.36.


Pediatrix Medical Group Net Income Historical Data

The historical data trend for Pediatrix Medical Group's Net Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pediatrix Medical Group Net Income Chart

Pediatrix Medical Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -796.49 130.96 66.34 -60.41 -99.07

Pediatrix Medical Group Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Net Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -124.29 4.04 -153.03 19.44 30.48

Pediatrix Medical Group Net Income Calculation

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.

Net Income
= Revenue - Cost of Goods Sold - Selling, General, & Admin. Expense - Research & Development - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= EBITDA - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Operating Income - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Pre-Tax Income - Tax Expense + Others

Pediatrix Medical Group's Net Income for the fiscal year that ended in Dec. 2024 is calculated as

Net Income(A: Dec. 2024 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=-101.341+2.272+0+-1.4210854715202E-14
=-99

Pediatrix Medical Group's Net Income for the quarter that ended in Dec. 2024 is calculated as

Net Income(Q: Dec. 2024 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=33.328+-2.848+0+-3.5527136788005E-15
=30

Net Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-99 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pediatrix Medical Group  (NYSE:MD) Net Income Explanation

Net Income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:

Pediatrix Medical Group's Earnings per Share (Diluted) (EPS) for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

EPS is most useful for companies that have:

A predictable business
Consistent accounting methods
And few restructurings

The dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred Net Income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Pediatrix Medical Group Net Income Related Terms

Thank you for viewing the detailed overview of Pediatrix Medical Group's Net Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Pediatrix Medical Group Business Description

Traded in Other Exchanges
Address
1301 Concord Terrace, Sunrise, FL, USA, 33323
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
Executives
Mark S Ordan director, officer: Chief Executive Officer 7315 WISCONSIN AVENUE, SUITE #250 WEST, BETHESDA MD 20814
Moore Mary Ann E officer: EVP Chief ERM/Legal Ops Off 1301 CONCORD TERRACE, SUNRISE FL 33323
James D Swift officer: EVP, Chief Operating Officer 1301 CONCORD TERRACE, SUNRISE FL 33323
Laura A Linynsky director 1301 CONCORD TERRACE, SUNRISE FL 33323
C Marc Richards officer: EVP, Chief Financial Officer 7315 WISCONSIN AVENUE, SUITE 250-W, BETHESDA MD 20814
Shirley A Weis director 11621 RESEARCH CIRCLE, GAINESVILLE FL 32615
Sylvia Jean Young director C/O LINCOLN EDUCATIONAL SERVICES CORPORA, 14 SYLVAN WAY, STE. A, PARSIPPANY NJ 07054
Curtis Pickert officer: EVP, Chief Operating Officer 1301 CONCORD TERRACE, SUNRISE FL 33323
Lee Wood officer: EVP, Natl & Market Operations 1301 CONCORD TERRACE, SUNRISE FL 33323
Roger Md Medel director, officer: PRES. & CHIEF EXEC. OFFICER 1301 CONCORD TERRACE, SUNRISE FL 33323
Roger Mack Hinson officer: Pres., PDX & OBX Medical Group C/O MEDNAX, INC., 1301 CONCORD TERRACE, SUNRISE FL 33323
John C Pepia officer: Principal Accounting Officer 1301 CONCORD TERRACE, SUNRISE FL 33323
Dominic J Andreano officer: Sr.VP,General Counsel & Secy. 1301 CONCORD TERRACE, SUNRISE FL 33323
Nicholas Nikolopoulos officer: EVP Chf Strategy & Growth Offi MEDNAX INC, 1301, SUNRISE FL 33323
Thomas Mceachin director 11621 RESEARCH CIRCLE, ALACHUA FL 32615